6 completed, 1 terminated. 4 Phase 1, 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
| Phase 3 | 3 | Completed 2, Terminated 1 |
| Phase 2 | 1 | Completed 1 |
Follow ZX-7101A: new trials by email Literature Review of ZX-7101A trials Research Report on ZX-7101A
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Assess the Safety and Efficacy of ZX-7101A in Children Aged 5-11 Years With Influenza ZX-7101A, Placebo for ZX-7101A tablet, Oseltamivir phosphate dry suspension - Respiratory Viral Infection | Phase 3 | Terminated | Nanjing Zenshine Pharmaceuticals | 98 | 2024-10-31 | 2025-08-13 |
| Study to Assess the Safety and Efficacy of ZX-7101A in Adolescents With Influenza ZX-7101A, Placebo - Respiratory Viral Infection | Phase 3 | Completed | Nanjing Zenshine Pharmaceuticals | 361 | 2023-11-30 | 2025-02-19 |
| A Study to Evaluate Drug-drug Interaction of ZX-7101A Tablets and Oseltamivir Phosphate Capsules in Healthy Adult Subjects ZX-7101A, Oseltamivir, ZX-7101A and Oseltamivir - Drug Interaction | Phase 1 | Completed | Nanjing Zenshine Pharmaceuticals | 18 | 2023-08-28 | 2024-11-04 |
| A Study to Evaluate the Effect of a Single Oral Dose of ZX-7101A on the QTc Interval in Healthy Subjects ZX-7101A, Placebo - Influenza, Human | Phase 1 | Completed | Nanjing Zenshine Pharmaceuticals | 24 | 2023-07-08 | 2024-11-04 |
| A Study to Assess the Effect of Itraconazole Capsules on the Pharmacokinetics of ZX-7101A Tablets in Healthy Adult Subjects in China ZX-7101A - Pharmacokinetics | Phase 1 | Completed | Nanjing Zenshine Pharmaceuticals | 16 | 2023-07-02 | 2024-11-05 |
| A Study to Evaluate the Efficacy and Safety of ZX-7101A Tablets in Adults with Uncomplicated Influenza ZX-7101A - Influenza, Human | Phase 2 / Phase 3 | Completed | Nanjing Zenshine Pharmaceuticals | 900 | 2022-07-17 | 2024-11-05 |
| Study to Assess the Safety, Tolerability and Pharmacokinetics of ZX-7101A and the Food Effect in Healthy Volunteers ZX-7101A, Placebo - Safety Issues, Tolerance | Phase 1 | Completed | Nanjing Zenshine Pharmaceuticals | 66 | 2021-12-01 | 2023-07-21 |
Influenza, Human (3)
Nanjing Zenshine Pharmaceuticals (7)
China (7)
Hanmin Liu, MD (1) · Xiaoli Qin, PhD (1)